{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-004875","form_type":"8-K","ticker":"RTGN","cik":"0001836295","company_name":"RetinalGenix Technologies Inc.","filed_at":"2022-02-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.711575+00:00","generated_at":"2026-06-27T07:08:55.473610+00:00","sec_items":["1.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"RetinalGenix and Diopsys terminate 2019 Option Exchange Agreement; no options ever issued","bullets":["Termination effective Feb 14, 2022; Agreement from Oct 8, 2019 never had conditions satisfied.","No options were issued under the agreement, and the contemplated Exclusive Distribution Agreement was never negotiated.","Both parties are mutually released from any claims related to the Agreement and its termination.","RetinalGenix and Diopsys continue discussions toward a potential Exclusive Distribution Agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-004875","json":"https://secwatch.observer/filing/0001493152-22-004875.json","markdown":"https://secwatch.observer/filing/0001493152-22-004875.md","text":"https://secwatch.observer/filing/0001493152-22-004875.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1836295/000149315222004875/0001493152-22-004875-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1836295/000149315222004875/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T07:08:55.473610+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}